2045 Initiative
A project aiming to achieve cybernetic immortality by 2045
The 2045 Initiative is a nonprofit organization that aims to extend human life through the development of cybernetic technologies. Founded by Russian entrepreneur Dmitry Itskov in 2011, the initiative seeks to create a network of researchers in the field of life extension and artificial intelligence to achieve the goal of transferring human consciousness to a non-biological carrier by the year 2045.
Goals
The primary goal of the 2045 Initiative is to achieve cybernetic immortality by transferring human consciousness into an artificial body. This involves several stages of development:
- Avatar A: Creation of a robotic copy of a human body controlled via a brain-computer interface.
- Avatar B: Development of a system to transfer a human brain into a robotic body at the end of the biological body's life.
- Avatar C: Creation of an artificial brain in which human consciousness can be transferred.
- Avatar D: Development of a hologram-like avatar that can host human consciousness.
Research and Development
The 2045 Initiative collaborates with leading scientists in the fields of robotics, neuroscience, and artificial intelligence. The initiative promotes research into brain-computer interfaces, neural networks, and biomechanics to advance the development of avatars.
Brain-Computer Interfaces
Brain-computer interfaces (BCIs) are a critical component of the 2045 Initiative's research. BCIs enable direct communication between the brain and external devices, allowing for control of robotic avatars.
Artificial Intelligence
The initiative emphasizes the development of artificial intelligence to facilitate the transfer and maintenance of human consciousness in non-biological carriers.
Neuroscience
Research in neuroscience is essential for understanding the human brain and developing methods to replicate its functions in artificial systems.
Public Engagement
The 2045 Initiative actively engages with the public through conferences, publications, and online platforms. It aims to raise awareness about the potential of transhumanism and the ethical implications of immortality.
Criticism
The initiative has faced criticism from various quarters, including concerns about the feasibility of its goals, ethical considerations, and the potential societal impact of achieving immortality. Critics argue that the technology required to transfer human consciousness is still in its infancy and may not be achievable by 2045.
Related pages
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian